Journal article

Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy

Frederik van Delft, Mirte Muller, Rom Langerak, Hendrik Koffijberg, Valesca Retel, Daan van den Broek, Maarten IJzerman

MEDICAL DECISION MAKING | SAGE PUBLICATIONS INC | Published : 2021

Abstract

BACKGROUND: Although immunotherapy (IMT) provides significant survival benefits in selected patients, approximately 10% of patients experience (serious) immune-related adverse events (irAEs). The early detection of adverse events will prevent irAEs from progressing to severe stages, and routine testing for irAEs has become common practice. Because a positive test outcome might indicate a clinically manifesting irAE that requires treatment to (temporarily) discontinue, the occurrence of false-positive test outcomes is expected to negatively affect treatment outcomes. This study explores how the UPPAAL modeling environment can be used to assess the impact of test accuracy (i.e., test sensitivi..

View full abstract